9 of 9 Biotechnology Jobs in the Thames Valley

will be considered a strong fit if you have: Master's degree in engineering (such as AI/ML, Data Systems, Computer Science, Mathematics, Biotechnology, Physics), or minimum 2 years of relevant technology experience. Experience with Generative AI (GenAI) and agentic systems will be considered a strong plus. Have ...

Computer Vision Engineer Salary: £55,000 - £65,000 Location: Kidlington, Oxfordshire About the Role Our client is a small Biotech firm who are looking to hire a Computer Vision Engineer on a permanent basis. The company is based in Kidlington, Oxfordshire and the role is mostly office based with ...

keys — ensuring anonymity with accountability. We're an ambitious, self-financed start-up with our founders having an entrepreneurial background in AI, Hedge Funds, Biotech and Energy Production. We are headquartered in London with our technical team based across the UK and France. Operating independently allows us to move quickly ...

vivo gene therapy or gene-modified cell therapy). Oxford Biomedica collaborates with some of the world's most innovative pharmaceutical and biotechnology companies, providing viral vector development and manufacturing expertise in lentivirus, adeno-associated virus (AAV) and adenoviral vectors. Oxford Biomedica's world-class capabilities span from early-stage … experience in viral vectors; the driving force behind?the majority of?gene therapies. OXB collaborates with some of the worlds most innovative pharmaceutical and biotechnology companies, providing viral vector development and manufacturing?expertise?in lentivirus, adeno-associated virus (AAV)?and adenoviral vectors. OXBs world-class capabilities span from early-stage ...

vivo gene therapy or gene-modified cell therapy). Oxford Biomedica collaborates with some of the world's most innovative pharmaceutical and biotechnology companies, providing viral vector development and manufacturing expertise in lentivirus, adeno-associated virus (AAV) and adenoviral vectors. Oxford Biomedica's world-class capabilities span from early-stage … experience in viral vectors; the driving force behind?the majority of?gene therapies. OXB collaborates with some of the worlds most innovative pharmaceutical and biotechnology companies, providing viral vector development and manufacturing?expertise?in lentivirus, adeno-associated virus (AAV)?and adenoviral vectors. OXBs world-class capabilities span from early-stage ...

Evaluate new tools and technologies with external vendors and integrate them into existing workflows. What We’re Looking For: Experience in automation engineering, robotics, biotech, or industrial systems integration. Proven track record of designing and deploying robust automation systems, including multi-device orchestration. Skilled in firmware-level control, driver development … Robotics, or similar. Familiarity with open-source automation libraries, such as PyLabRobot. Experience creating digital twins or virtual representations of lab devices. Background in biotech, pharma, materials science, or other R&D areas that rely heavily on automation. Offices and Lab located in Oxford. Hybrid working c.3 days in office ...

vivo gene therapy or gene-modified cell therapy). Oxford Biomedica collaborates with some of the world's most innovative pharmaceutical and biotechnology companies, providing viral vector development and manufacturing expertise in lentivirus, adeno-associated virus (AAV) and adenoviral vectors. Oxford Biomedica's world-class capabilities span from early-stage … experience in viral vectors; the driving force behind the majority of gene therapies. OXB collaborates with some of the worlds most innovative pharmaceutical and biotechnology companies, providing viral vector development and manufacturing expertise in lentivirus, adeno-associated virus (AAV)and adenoviral vectors. OXBs world-class capabilities span from early-stage ...

vivo gene therapy or gene-modified cell therapy). Oxford Biomedica collaborates with some of the world's most innovative pharmaceutical and biotechnology companies, providing viral vector development and manufacturing expertise in lentivirus, adeno-associated virus (AAV) and adenoviral vectors. Oxford Biomedica's world-class capabilities span from early-stage … experience in viral vectors; the driving force behind the majority of gene therapies. OXB collaborates with some of the worlds most innovative pharmaceutical and biotechnology companies, providing viral vector development and manufacturing expertise in lentivirus, adeno-associated virus (AAV) and adenoviral vectors. OXBs world-class capabilities span from early-stage ...

vivo gene therapy or gene-modified cell therapy). Oxford Biomedica collaborates with some of the world's most innovative pharmaceutical and biotechnology companies, providing viral vector development and manufacturing expertise in lentivirus, adeno-associated virus (AAV) and adenoviral vectors. Oxford Biomedica's world-class capabilities span from early-stage … experience in viral vectors; the driving force behind the majority of gene therapies. OXB collaborates with some of the worlds most innovative pharmaceutical and biotechnology companies, providing viral vector development and manufacturing expertise in lentivirus, adeno-associated virus (AAV) and adenoviral vectors. OXBs world-class capabilities span from early-stage ...